HAEMATOLOGICAL MALIGNANCY
Clinical trials for HAEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HAEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HAEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could existing melanoma drugs work for other rare cancers? new trial aims to find out.
Disease control Not yet recruitingThis trial tests whether two drugs, dabrafenib and trametinib, already approved for melanoma and lung cancer, can help people with other rare cancers that have a BRAF V600 mutation. About 30 adults, children, and teenagers with these rare cancers will receive the drug combination…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Are CLL patients getting fair referrals? new study investigates
Knowledge-focused Not yet recruitingThis study surveys doctors and nurses to understand how they decide to refer people with chronic lymphocytic leukemia (CLL) to specialists. The goal is to find differences in care across the West Midlands region and suggest ways to make referrals fairer for all patients. About 13…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated May 01, 2026 16:01 UTC